Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1250 of 5804
-
Engineered immune cells take on Hard-to-Treat colorectal cancer
Disease control TerminatedThis is an investigator initiated trial to assess the efficacy and safety of a GCC-targeting CAR-T therapy (WD-01) in the metastatic colorectal cancer.
Phase: EARLY_PHASE1 • Sponsor: Wondercel Biotech (ShenZhen) • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Blood thinners after birth: could they save lives of new moms at moderate risk?
Prevention Recruiting nowVenous thromboembolism (VTE) is currently the second cause of death in women of reproductive age worldwide. The incidence of VTE during pregnancy is 1.2 to 1.4/1000 women, half of VTE occurring during postpartum and as PE in majority of cases, accounting for 8.8% of maternal deat…
Phase: PHASE4 • Sponsor: University Hospital, Brest • Aim: Prevention
Last updated Jun 27, 2026 13:08 UTC
-
Could a diabetes pill ease pressure on failing fontan hearts?
Disease control Recruiting nowThe purpose of this research is to determine whether treatment with the study drug dapagliflozin for 3 months affects peripheral venous pressure at rest and during exercise in adults with failing Fontan circulation.
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New study tests kidney cancer combo in patients over 70
Disease control Recruiting nowThe goal of the study is to describe real-life use and exposition to nivolumab-cabozantinib among older patients with metastatic clear-cell renal cell cancer
Phase: PHASE4 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New combo therapy targets tough lung cancer
Disease control OngoingThe primary objective of this study is to evaluate the safety and tolerability of tarlatamab in combination with YL201 with or without anti-PD-L1.
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New scan could spot hidden prostate cancer early
Diagnosis OngoingThe aim for this study is to investigate the ability of 64Cu-SAR-bisPSMA PET/CT to detect recurrence of prostate cancer
Phase: PHASE3 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
New shot SH009 targets tough cancers in early trial
Disease control Recruiting nowEvaluate the efficacy and safety of SH009 injection therapy for patients with advanced solid tumors
Phase: PHASE1 • Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
300 CF patients join study to unlock secrets of dangerous lung Flare-Ups
Knowledge-focused Recruiting nowThe CF-Tracker study is a community surveillance study, designed to understand the causes of exacerbations in people with cystic fibrosis (CF) (pwCF). These are episodes when pwCF become more unwell, typically characterised by increased cough, sputum, and breathlessness, and requ…
Sponsor: Alexander Horsley • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Exercise may boost Well-Being in advanced colorectal cancer patients
Symptom relief Recruiting nowThe primary objective of this trial is to compare the effects of 18 weeks structured exercise training versus on control on healt-related quality of life in patients with mCRC undergoing first-line chemotherapy.
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New hope for eczema sufferers: experimental drug GHZ339 enters Mid-Stage trial
Symptom relief Recruiting nowThis trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Fish oil infusions tested to tame transplant complication
Disease control ENROLLING_BY_INVITATIONStudy Title: A Study on the Effects and Mechanisms of Omega-3 Polyunsaturated Fatty Acids on Acute Graft-Versus-Host Disease (aGVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation Study Type: Open-label, randomized, single-center proof-of-concept clinical trial …
Phase: PHASE1, PHASE2 • Sponsor: Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New Laser-Ointment combo could replace surgery for skin cancer
Disease control Recruiting nowThe investigators seek to evaluate the effectiveness of fractional laser therapy and tirbanibulin ointment to treat squamous and basal cell carcinomas. This will be executed by using both thulium and erbium lasers on previously biopsy-confirmed SCCs and BCCs and applying bulk hea…
Phase: PHASE1, PHASE2 • Sponsor: Bruce Robinson, MD • Aim: Disease control
Last updated Jun 26, 2026 18:45 UTC
-
Robotic suits could help stroke patients regain their stride
Symptom relief Recruiting nowThe purpose of this research study is to evaluate and compare different robotic exoskeletons (RE) and identify which is most appropriate for gait training for each patient based off their specific needs. This will help guide clinicians in prescribing the appropriate RE for rehabi…
Phase: NA • Sponsor: Kessler Foundation • Aim: Symptom relief
Last updated Jun 26, 2026 13:04 UTC
-
Custom graft offers new hope for aneurysm patients
Disease control Recruiting nowThe purpose of this study is to assess the effects of a physician-modified endovascular graft (PMEG) for juxtarenal aortic aneurysms by collecting data on its performance. Participants in the study will undergo surgery to repair their juxtarenal aortic aneurysm using the PMEG dev…
Phase: NA • Sponsor: Cali Johnson • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug trial aims to tame esophageal inflammation
Disease control Recruiting nowThis is a prospective, open-label drug study that will examine the effects of Zemaira (alpha-1 trypsin inhibitor) in patients with Eosinophilic Esophagitis.
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New study tracks Ravulizumab's impact on daily life in myasthenia gravis
Disease control Recruiting nowThe Polish multicentre observational (non-interventional) study aiming to collect data on the management and clinical outcomes of patients with gMG that received ravulizumab.
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for advanced cancers: first human trial of DXC008 begins
Disease control Recruiting nowThis is a phase I, open-label, first-in-human clinical study designed to evaluate the safety, tolerability, MTD, DLT, RP2D, the PK characteristics, preliminary anti-tumor activity, the immunogenicity of DXC008 in patients with prostate cancer and other solid tumors such as Ewing …
Phase: PHASE1 • Sponsor: Hangzhou DAC Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New combo therapy aims to control advanced colorectal cancer
Disease control Recruiting nowPhase II study of simultaneous infusion of levozolinate for injection and 5-FU as first-line treatment for advanced colorectal cancer
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can a phone app lower blood pressure in African-Americans? new study aims to find out.
Disease control Recruiting nowThe purpose of this study is to test the hypertension (HTN) app-based intervention to see if it is more effective in improving uncontrolled HTN and HTN self-care among Africian-Americans from baseline to post-intervention (immediate, 3 months and 6 months post-intervention) as co…
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New drug shows promise in cutting heavy drinking days
Disease control OngoingThis is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in the treatment of AUD in subjects with obesity or overweight. After signing the informed consent form, subjects will be screened and if eligible…
Phase: PHASE2 • Sponsor: Altimmune, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC